Holen Sie sich die Stockscreener-App
4.41
1.05%
-0.010
Pmgc Holdings Inc Aktie (ELAB) Neueste Nachrichten
PMGC Holdings Inc. Announces Filing of Annual Report on Form 10-K - The Manila Times
PMGC Holdings Targets Multiple Acquisitions to Accelerate Growth Strategy - Stock Titan
PMGC Holdings Inc. SEC 10-K Report - TradingView
PMGC subsidiary signs amended licensing agreement with MOA Life Plus - TipRanks
NorthStrive Biosciences Inc. Signs Amended Licensing Agreement with Existing Licensor, Aims to Capture Animal Health Market - GlobeNewswire
Major Market Move: NorthStrive Secures Rights to Tap $12.65B Animal Health Industry - Stock Titan
Univest Securities, LLC Announces Closing of $1.48 Million Registered Direct Offering for its Client PMGC Holdings Inc. (NASDAQ: ELAB) - The Manila Times
Univest Securities, LLC Announces Closing of $1.48 Million - GlobeNewswire
PMGC Holdings strikes deal to exercise warrants, raise $1.9 million - MSN
Form 424B5 PMGC Holdings Inc. - StreetInsider
PMGC Holdings secures $1.48 million in direct offering - Investing.com India
PMGC Holdings Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules - MarketScreener
PMGC Holdings secures $1.48 million in direct offering By Investing.com - Investing.com South Africa
PMGC Holdings Inc. Announces $1.48 Million Registered Direct Offering Priced At-The Market Under Nasdaq Rules - GlobeNewswire
PMGC Holdings Raises Fresh Capital: $1.48M Strategic Financing Deal Revealed - StockTitan
PMGC Holdings announces share repurchase from existing investors By Investing.com - Investing.com Canada
PMGC Holdings Inc’s (ELAB) 13.48% Gain Is A Reason To Reconsider. - Stocks Register
PMGC Holdings Announces Share Repurchases from Existing Shareholders - GlobeNewswire
ELAB stock plunges to 52-week low, touches $4.15 By Investing.com - Investing.com Australia
ELAB stock plunges to 52-week low, touches $4.15 - Investing.com
PMGC Holdings executes modest stock repurchase By Investing.com - Investing.com South Africa
PMGC Holdings executes modest stock repurchase - Investing.com
Northstrive Biosciences Inc. Schedules Pre-IND Meeting with - GlobeNewswire
Northstrive Biosciences plans meeting with FDA for its new obesity reducing therapy -March 10, 2025 at 11:15 am EDT - Marketscreener.com
Northstrive Biosciences plans meeting with FDA for its new obesity reducing therapy - TradingView
Is PMGC Holdings (NASDAQ:ELAB) In A Good Position To Invest In Growth? - simplywall.st
Is PMGC Holdings (NASDAQ:ELAB) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
PMGC it has schedules a pre-IND meeting with FDA for EL-22 - TipRanks
ELABPMGC Holdings Latest Stock News & Market Updates - StockTitan
Is PMGC Holdings Inc (NASDAQ: ELAB) A Good Investment For New Investors Now? - Stocks Register
Nasdaq Down Over 400 Points; Kroger Posts Upbeat Earnings - Benzinga India
ELAB’s price-to-free cash flow ratio: What it means for investors - US Post News
PMGC Holdings announces reverse stock split By Investing.com - Investing.com Australia
PMGC to Implement 1-for-7 Reverse Stock Split; Shares Fall -March 06, 2025 at 10:48 am EST - Marketscreener.com
Dow Tumbles 1%; US Initial Jobless Claims DeclineAclarion (NASDAQ:ACON), AGM Gr Hldgs (NASDAQ:AGMH) - Benzinga
PMGC Holdings announces reverse stock split - Investing.com
PMGC announces 1-for-7 reverse stock split - TipRanks
PMGC Holdings Inc. Announces 1-for-7 Reverse Stock Split Effective March 10, 2025 - Nasdaq
PMGC Holdings Inc. Announces Reverse Stock Split to Maintain Nasdaq Listing Compliance - The Manila Times
PMGC Holdings Announces Reverse Stock Split To Maintain Nasdaq Listing Compliance - Marketscreener.com
Can PMGC's Reverse Split Save Its Nasdaq Listing? Key Details Revealed - StockTitan
Elevai Labs stock plunges to 52-week low of $1.16 amid steep decline - Investing.com India
PMGC Holdings Ends License Agreement with INmune Bio By Investing.com - Investing.com South Africa
PMGC Holdings Ends License Agreement with INmune Bio - Investing.com
2.65%
0.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):